Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Green-lipped mussel (Perna canaliculus) contains omega-3 fatty acids and glycosaminoglycans that reduce inflammation by inhibiting 5-lipoxygenase and cyclooxygenase pathways. This marine mollusk extract provides targeted joint support by blocking inflammatory mediators while supplying cartilage-building compounds.
Reported Benefits (Provisional)
Origin & History
Green-Lipped Mussels are native to New Zealand and are harvested for their unique anti-inflammatory compounds, including omega-3 fatty acids.
Research Narrative (Provisional)
Clinical trials have shown that Green-Lipped Mussel extract can reduce joint pain and improve mobility in arthritis patients.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Green-Lipped Mussel (Perna canaliculus) is a nutrient-dense shellfish with a complex bioactive profile. Per 100g dry weight extract: Protein: 55-65g (complete protein containing all essential amino acids, including glycine ~6g, proline ~4g, and hydroxyproline ~3g critical for connective tissue). Fat: 8-12g total lipids, of which omega-3 fatty acids comprise 15-20% of total lipids (~1.5-2g per 100g extract), notably eicosapentaenoic acid (EPA ~300-500mg), docosahexaenoic acid (DHA ~150-250mg), and uniquely eicosatetraenoic acid (ETA, 18:4n-3, ~50-100mg), a rare omega-3 not found in fish oil. Carbohydrates: 12-18g including glycosaminoglycans (GAGs) such as chondroitin sulfate (~2-4g) and hyaluronic acid (~0.5-1g). Ash/Minerals: 8-12g. Key micronutrients per 100g dry extract — Zinc: 25-40mg (high bioavailability, supports immune and enzymatic function); Iron: 15-20mg (heme iron, bioavailability ~25-30%); Selenium: 45-90mcg; Copper: 1-3mg; Manganese: 2-5mg; Magnesium: 150-200mg; Calcium: 120-180mg; Phosphorus: 400-600mg; Iodine: 100-200mcg. Vitamins: B12: 15-25mcg (exceptionally high, highly bioavailable cyanocobalamin/methylcobalamin forms); Vitamin E (tocopherols): 8-15mg acting synergistically with lipid fraction; Vitamin C: trace amounts (~5-10mg); Folate: 40-60mcg; Niacin (B3): 3-5mg; Riboflavin (B2): 0.3-0.6mg. Bioactive compounds: Furan fatty acids (F-acids): present in small but bioactive quantities (~0.1-0.3% of lipid fraction), contributing to anti-inflammatory activity; Carotenoids: astaxanthin and beta-carotene (~1-3mg combined); Sterols: cholesterol and brassicasterol (~200-400mg); Taurine: ~500-800mg per 100g, supporting cardiovascular and neurological function; Nucleotides and nucleosides present in moderate quantities. Bioavailability notes: The lipid fraction of GLM extract demonstrates superior bioavailability compared to fish oil due to the phospholipid-bound omega-3 structure, which enhances intestinal absorption by approximately 30-50%. The GAG fraction is partially hydrolyzed during digestion, with chondroitin sulfate showing ~13-15% systemic absorption. Standardized commercial extracts (e.g., Lyprinol/PCSO-524) concentrate the lipid fraction 200-fold, delivering ~50mg lipid extract per softgel with consistent ETA and EPA ratios. Whole powder preparations retain the full nutritional matrix but require higher doses (500-1000mg/day) to achieve comparable clinical effects.
Reported Mechanism (Provisional)
Green-lipped mussel's omega-3 fatty acids, particularly EPA and DHA, inhibit 5-lipoxygenase and cyclooxygenase enzymes that produce inflammatory leukotrienes and prostaglandins. The glycosaminoglycans and chondroitin sulfate components support cartilage matrix synthesis by stimulating proteoglycan production. Additionally, furan fatty acids unique to this species modulate nuclear factor-kappa B pathways, reducing pro-inflammatory cytokine release.
Clinical Narrative (Provisional)
Multiple randomized controlled trials involving 50-80 participants show green-lipped mussel extract reduces joint pain by 25-40% over 8-12 weeks compared to placebo. A systematic review of 6 studies found significant improvements in joint stiffness and mobility scores in osteoarthritis patients. However, studies are generally small-scale and short-term, with heterogeneous dosing protocols ranging from 300-1500mg daily. More large-scale, long-term trials are needed to establish optimal therapeutic protocols.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.